|Podcasts|June 27, 2023
The Trust Factor In Data
The many sources of data source in clinical trials can be overwhelming, but the data itself can be used positively to guide clinical operations decision-making.
Advertisement
Craig Serra, Head of Commercial Solutions and Partnerships at Flatiron Health’s Clinical Research Business Unit, discusses data and its many uses in clinical trials that guide operational decision-making; how the people in that work in clinical trials make the difference and how to bring the next generation up in clinical trials.
About the speaker
Craig Serra is an industry veteran who is currently at Flatiron Health leading commercial and partnerships for the newly formed Clinical Research Business Unit. He previously held (senior) leadership roles at Novartis, Pfizer, Eisai, and Roche. He has 20+ years within global clinical development operations, spanning strategy, innovation, digital, functional, and business leadership roles. He has a passion to advance our collective mission for patients, with first-hand knowledge being a clinical trial participant himself. His graduate education spans clinical pharmacology, business, and information systems, while serving our industry through board appointments (Castor EDC, SCDM, Cristian Rivera Foundation), mentorship, direct support of cancer research, and volunteering.
About the ACT Podcast
The editors of Applied Clinical Trials bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
2
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
3
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
4
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
5